DABIGEN 110
DABIGEN 110 contains Dabigatran Etexilate 110 mg, an oral anticoagulant that helps prevent blood clots. It works by directly inhibiting thrombin, a key factor in clot formation. This medicine is commonly used in patients with atrial fibrillation to reduce the risk of stroke, and after certain surgeries. Regular use helps maintain smooth blood flow and lowers the chances of serious clot-related complications.
Related products
METOMED AM 25
METOMED AM 25 is a combination therapy used for effective management of hypertension and cardiovascular...
TELLME MT 50
TELLME MT 50 contains Telmisartan 40 mg + Metoprolol 50 mg. This combination helps manage...
TELLME TRIO CC
TELLME CC combines Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg. This...
TELLME 40 CT 6.25
TELLME 40 CT 6.25 includes Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 6.25...
TELLME H
TELLME H is a combination of Telmisartan 40 mg + Hydrochlorothiazide 12.5 mg. Telmisartan relaxes...
